title: Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.
abstract: Captopril and aspirin have been claimed to adversely affect renal function. This study was designed to evaluate the safety of concomitant administration of both drugs in patients with moderate to severe congestive heart failure (CHF). The study group consisted of 10 patients with a mean age of 77.6 +/- 4.4 years and a mean New York Heart Association functional class of 2.6 +/- 0.5. Captopril was administered in a rapidly escalating dose regimen over a 4-day period to a maximum dose of 75 mg/day. Aspirin 0.25 g/day was added from day 5 on. Renal plasma flow (RPF) was measured by iodohippurate scan and the creatinine clearance test (Ccr) was used as an index of glomerular filtration rate (GFR). Both Ccr and RPF remained unchanged throughout the study period; 48.9 +/- 16; 48.2 +/- 16.5; 49.4 +/- 16, and 222 +/- 67, 241 +/- 97, 237 +/- 88 ml/min, for days 0, 4, 9, respectively. Only 1 patient developed a significant decrease in Ccr following the administration of captopril. This patient had a further decrease when aspirin was added. The decrease in Ccr was accompanied by a marked reduction in filtration fraction and in mean arterial pressure. Our data suggest that the administration of aspirin to elderly patients with moderate CHF treated with captopril is relatively safe and is not associated with further deterioration in renal function.
authors.affiliation: Department of Medicine T, Ichilov Hospital, Tel-Aviv Sourasky Medical Center, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Schwartz
authors.forename: R
authors.initials: R
authors.lastname: Kornowski
authors.forename: H
authors.initials: H
authors.lastname: Lehrman
authors.forename: M
authors.initials: M
authors.lastname: Averbuch
authors.forename: A
authors.initials: A
authors.lastname: Pines
authors.forename: M
authors.initials: M
authors.lastname: Greenland
authors.forename: A
authors.initials: A
authors.lastname: Finkelstein
authors.forename: Y
authors.initials: Y
authors.lastname: Levo
mesh_terms: D000368:Aged; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D001783:Blood Flow Velocity / Q000187:drug effects; D002216:Captopril / Q000008:administration & dosage / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D004573:Electrolytes / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000098:blood supply*; D007677:Kidney Function Tests; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy
chemical_list: D004573:Electrolytes; D002216:Captopril; D003404:Creatinine; D001241:Aspirin